Lantheus Holdings, Inc. (LNTH) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m); Long-term Debt and Lease Obligation, Including Current MaturitiesUSD (m).
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $697.00K; Long-term Debt and Lease Obligation, CurrentUSD $697.00K; Long-term Debt and Lease ObligationUSD $570.35M; Long-term Debt and Lease Obligation, Including Current MaturitiesUSD $571.05M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $803.00K; Long-term Debt and Lease Obligation, CurrentUSD $803.00K; Long-term Debt and Lease ObligationUSD $569.60M; Long-term Debt and Lease Obligation, Including Current MaturitiesUSD $570.41M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $738.00K; Long-term Debt and Lease Obligation, CurrentUSD $738.00K; Long-term Debt and Lease ObligationUSD $568.68M; Long-term Debt and Lease Obligation, Including Current MaturitiesUSD $569.42M.
Lantheus Holdings, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt and Lease Obligation, Current USD | Long-term Debt and Lease Obligation USD | Long-term Debt and Lease Obligation, Including Current Maturities USD | Debt Instrument, Convertible, If-converted Value in Excess of Principal USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Debt Instrument, Unamortized Discount USD | Debt Instrument, Unamortized Premium USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | (m) | 6 month · $2.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-06-30 | $697.00K | $697.00K | $570.35M | $571.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $803.00K | $803.00K | $569.60M | $570.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $738.00K | $738.00K | $568.68M | $569.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $871.00K | $871.00K | $567.94M | $568.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $796.00K | $796.00K | $566.85M | $567.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $747.00K | $747.00K | $566.10M | $566.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $974.00K | $974.00K | $565.28M | $566.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $564.71M | $564.71M | $613.00K | $565.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $868.00K | $868.00K | $563.19M | $564.06M | (m) | (m) | (m) | $0.00 | $0.00 | $575.00M | (m) | (m) | $0.00 | $575.00M | (m) | (m) | (m) |
| 2024-03-31 | $734.00K | $734.00K | $562.47M | $563.20M | (m) | (m) | (m) | $0.00 | $0.00 | $575.00M | (m) | (m) | $0.00 | $575.00M | (m) | (m) | (m) |
| 2023-12-31 | $823.00K | $823.00K | $561.67M | $562.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $575.00M | $0.00 | (m) | $575.00M | (m) | (m) | (m) |
| 2023-09-30 | $703.00K | $703.00K | $560.58M | $561.28M | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $575.00M | (m) | $0.00 | $575.00M | (m) | (m) | (m) |
| 2023-06-30 | $384.00K | $384.00K | $559.24M | $559.62M | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $575.00M | (m) | $0.00 | $575.00M | (m) | (m) | (m) |
| 2023-03-31 | $422.00K | $422.00K | $558.54M | $558.96M | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $575.00M | (m) | $0.00 | $575.00M | (m) | (m) | (m) |
| 2022-12-31 | $354.00K | (m) | $557.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $557.71M | $558.07M | $0.00 | $0.00 | $0.00 | $0.00 | $575.00M | (m) | $575.00M | (m) | (m) | (m) |
| 2022-09-30 | $15.37M | $15.37M | $152.06M | $167.43M | (m) | (m) | (m) | $15.00M | $148.75M | (m) | (m) | (m) | $3.75M | $167.50M | (m) | $348.00K | (m) |
| 2022-06-30 | $14.06M | $14.06M | $155.66M | $169.73M | (m) | (m) | (m) | $15.00M | $148.75M | (m) | (m) | (m) | $6.25M | $170.00M | (m) | $399.00K | (m) |
| 2022-03-31 | $12.88M | $12.88M | $159.37M | $172.25M | (m) | (m) | (m) | $15.00M | $148.75M | (m) | (m) | (m) | $8.75M | $172.50M | (m) | $448.00K | (m) |
| 2021-12-31 | $11.64M | (m) | (m) | (m) | (m) | $163.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $163.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $174.76M | $11.25M | $15.00M | $148.75M | (m) | (m) | (m) | $175.00M | (m) | $498.00K | (m) |
| 2021-09-30 | $10.36M | $10.36M | $166.74M | $177.10M | (m) | (m) | (m) | $11.25M | $15.00M | $148.75M | (m) | (m) | $2.50M | $177.50M | (m) | $548.00K | (m) |
| 2021-06-30 | $10.37M | $10.37M | $169.25M | $179.62M | (m) | (m) | (m) | $11.25M | $15.00M | $148.75M | (m) | (m) | $5.00M | $180.00M | (m) | $598.00K | (m) |
| 2021-03-31 | $10.25M | (m) | (m) | (m) | (m) | $171.47M | $181.72M | $11.25M | $15.00M | $148.75M | (m) | (m) | $7.50M | $182.50M | (m) | $647.00K | (m) |
| 2020-12-31 | $20.70M | (m) | (m) | (m) | (m) | $197.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $197.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $218.40M | $20.45M | $26.30M | $22.05M | $148.75M | (m) | (m) | $217.55M | (m) | (m) | $954.00K |
| 2020-09-30 | $18.14M | (m) | (m) | (m) | (m) | $204.67M | $222.81M | $19.59M | $26.22M | $22.93M | $148.75M | (m) | $4.33M | $221.81M | (m) | (m) | $1.23M |
| 2020-06-30 | $17.14M | (m) | (m) | (m) | (m) | $210.01M | $227.15M | $21.93M | $30.64M | $15.97M | $148.75M | (m) | $8.61M | $225.90M | (m) | $1.57M | (m) |
| 2020-03-31 | $10.14M | (m) | (m) | (m) | (m) | $181.49M | $191.63M | (m) | $10.00M | $11.25M | $15.00M | $148.75M | $7.50M | $192.50M | (m) | $458.00K | (m) |
| 2019-12-31 | $10.14M | (m) | (m) | (m) | (m) | $183.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $194.07M | $10.00M | $10.00M | $11.25M | $15.00M | $148.75M | (m) | $195.00M | (m) | $485.00K | (m) |
| 2019-09-30 | $10.17M | (m) | (m) | (m) | (m) | $186.37M | $196.54M | (m) | $10.00M | $10.00M | $11.25M | $15.00M | $2.50M | $197.50M | (m) | $512.00K | (m) |
| 2019-06-30 | $10.14M | (m) | (m) | (m) | (m) | $188.71M | $198.84M | (m) | $10.00M | $10.00M | $11.25M | $15.00M | $5.00M | $200.00M | (m) | $539.00K | (m) |
| 2019-03-31 | $2.85M | (m) | (m) | (m) | (m) | $263.29M | $266.15M | (m) | $2.75M | $2.75M | $261.94M | (m) | $2.06M | $269.50M | (m) | $1.47M | (m) |
| 2018-12-31 | $2.75M | (m) | (m) | (m) | (m) | $263.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $2.75M | (m) | (m) | (m) | (m) | $264.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $2.75M | (m) | (m) | (m) | (m) | $264.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $2.75M | (m) | (m) | (m) | (m) | $264.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $2.75M | (m) | (m) | (m) | (m) | $265.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $2.75M | (m) | (m) | (m) | (m) | $265.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $2.75M | (m) | (m) | (m) | (m) | $265.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $2.75M | (m) | (m) | (m) | (m) | $266.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $3.65M | (m) | (m) | (m) | (m) | $274.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $3.65M | (m) | (m) | (m) | (m) | $294.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $3.65M | (m) | (m) | (m) | (m) | $348.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $3.65M | (m) | (m) | (m) | (m) | $349.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $3.65M | (m) | (m) | (m) | (m) | $349.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $3.65M | (m) | (m) | (m) | (m) | $350.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $3.65M | (m) | (m) | (m) | (m) | $350.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $392.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |